Analyst Price Target is $3.00
▲ +112.77% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Stealth BioTherapeutics in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 112.77% upside from the last price of $1.41.
Current Consensus is
The current consensus among 2 investment analysts is to buy stock in Stealth BioTherapeutics. This Buy consensus rating has held steady for over two years.